Molbio Diagnostics Ltd. IPO

The diagnostics industry is increasingly recognised as the cornerstone of India’s expanding healthcare sector, propelled by the essential need for accurate diagnosis as the first step in effective healthcare delivery. This market encompasses a wide range of tests and procedures, classified ... broadly as in vitro diagnosis (pathological tests), which involve tests performed on samples taken from the human body, and in vivo tests (radiology), which involve tests and procedures within the living body to visualise or measure internal body functions and structures. The Indian diagnostics market has shown significant growth between Fiscal 2021 to 2026 and is projected to continue this robust trend through Fiscal 2031. The diagnostics market was valued at ? 725.8 billion (USD 10.31 billion) in Fiscal 2021 and grew to ? 1,354.2 billion (USD 15.3 billion) in Fiscal 2026, at a CAGR of 13.3% for the said period. The in vitro diagnostics market (IVD) accounts for 56.1% of the diagnostics market, valued at ? 760.5 billion (USD 8.6 billion) in Fiscal 2026. Looking ahead, the diagnostics market is projected to grow at a CAGR of 11.7% from Fiscal 2026 to 2031 and is estimated to reach a market value of ? 2,356.5 billion (USD 26.6 billion) in Fiscal 2031. This growth trajectory will be propelled by the growing incidence of chronic illnesses, increasing demand for preventive screenings, rising geriatric population, and government healthcare access programs. The Indian in vitro diagnostics (IVD) market can be studied under the following segments: Based on techniques: 1) Immunodiagnostics – This segment utilises immunoassays to detect specific molecules such as antibodies or antigens in biological samples. It includes techniques such as ELISA (Enzyme-linked immunosorbent assay) and CLIA (Chemiluminescent immunoassay). 2) Haematology – Focuses on analysing blood components such as red blood cells, white blood cells, and platelets to diagnose conditions such as anaemia, infections, and leukaemia. Haematology analysers are commonly used in this segment. 3) Molecular diagnostics – Involves analysing nucleic acids (DNA, RNA) to detect genetic disorders, infections, and cancers. Techniques include PCR (Polymerase chain reaction) for amplifying DNA segments and sequencing technologies for analysing genetic sequences. 4) Clinical chemistry – Encompasses the analysis of blood serum, plasma, or urine to measure substances such as electrolytes, enzymes, and hormones. Techniques such as spectrophotometry and chromatography are used to quantify these substances. 5) Other IVD – Includes other diagnostic techniques and tools not covered explicitly by the above segments. It may include coagulation testing, urinalysis, and specialised tests for specific biomarkers or conditions. Read more